Canada markets closed

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
3.2600+0.0700 (+2.19%)
At close: 04:00PM EDT
3.3100 +0.05 (+1.53%)
After hours: 07:45PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 89.18M
Enterprise Value 42.35M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)19.91
Price/Book (mrq)6.01
Enterprise Value/Revenue 12.10
Enterprise Value/EBITDA -0.84

Trading Information

Stock Price History

Beta (5Y Monthly) 1.48
52-Week Change 30.62%
S&P500 52-Week Change 322.36%
52 Week High 39.0100
52 Week Low 32.8300
50-Day Moving Average 37.2156
200-Day Moving Average 35.0402

Share Statistics

Avg Vol (3 month) 3519.74k
Avg Vol (10 day) 31.28M
Shares Outstanding 527.36M
Implied Shares Outstanding 627.36M
Float 819.08M
% Held by Insiders 14.94%
% Held by Institutions 159.94%
Shares Short (Apr 15, 2024) 42.06M
Short Ratio (Apr 15, 2024) 46.82
Short % of Float (Apr 15, 2024) 47.93%
Short % of Shares Outstanding (Apr 15, 2024) 47.54%
Shares Short (prior month Mar 15, 2024) 41.7M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Jul 05, 2022

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,377.14%

Management Effectiveness

Return on Assets (ttm)-46.99%
Return on Equity (ttm)-260.60%

Income Statement

Revenue (ttm)3.5M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)-100.00%
Gross Profit (ttm)N/A
EBITDA -45.91M
Net Income Avi to Common (ttm)-54.19M
Diluted EPS (ttm)-2.5300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)52.23M
Total Cash Per Share (mrq)1.91
Total Debt (mrq)5.4M
Total Debt/Equity (mrq)36.42%
Current Ratio (mrq)4.15
Book Value Per Share (mrq)0.56

Cash Flow Statement

Operating Cash Flow (ttm)-37.01M
Levered Free Cash Flow (ttm)-18.89M